PTCT insider transactions
PTC Therapeutics Inc. (PTCT) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
PTCT insiders
Everyone who has filed a Form 3, 4, 5 or 144 at PTC Therapeutics Inc., latest first. Follow anyone to get their next filing.
- Steele Glenn Jr Md PhdDirector-$1.7M
- Michael SchmertzlerDirector-$6.4M
- Mark Elliott BouldingExec. VP and Clo-$24.7M
- Matthew B. KleinChief Executive Officer, Director-$7.27M
- Hege Elisabeth Sollie-ZetlmayerDirector, since July 2026
- Pierre GravierChief Financial Officer, since July 2023+$199K-$972K
- Mary L. SmithDirector, since June 2021-$1.43M
- Neil Gregory AlmsteadChief Technical Ops Officer-$30.4M
- Christine Marie UtterSVP, Chief Accounting Officer-$5.75M
- Eric PauwelsChief Business Officer-$12.2M
- Lee Scott GoldenEVP & Chief Medical Officer, since June 2023-$1.38M
- Jessica Caroline ChutterDirector, since March 2026
- Stephanie OkeyDirector-$1.92M
- Alethia YoungDirector, since June 2022-$465K
- Emma ReeveDirector-$5.98M
- David P SouthwellDirector-$1.86M
- Jerome B ZeldisDirector-$2M
- Allan Steven JacobsonDirector-$4.6M
- William F. Bell Jr.Director, since June 2023
- Almstead Zheng YangInsider
- Emily Luisa HillOfficer-$855K
- Stuart Walter PeltzOfficer, Director-$737K
- Dawn SvoronosDirector-$83.8K
Recent Form 3, 4, and 5 filings for PTCT
- Director Schmertzler Michael sold $149,037 worth of shares (2,500 units at $59.61) as part of a pre-agreed trading plan (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- EXEC. VP AND CLO Boulding Mark Elliott sold $12,338 worth of shares (192 units at $64.26) as part of a pre-agreed trading plan (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- Director Schmertzler Michael sold $158,480 worth of shares (2,500 units at $63.39) as part of a pre-agreed trading plan (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- EXEC. VP AND CLO Boulding Mark Elliott sold $132,791 worth of shares (2,073 units at $64.06) as part of a pre-agreed trading plan (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- Director Steele Glenn Jr Md Phd exercised 12,000 shares at a strike of $11.23 and sold $781,920 worth of shares (12,000 units at $65.16) as part of a pre-agreed trading plan (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- Director Schmertzler Michael sold $1,349,728 worth of shares (20,000 units at $67.49) as part of a pre-agreed trading plan (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- Director Schmertzler Michael sold $1,351,803 worth of shares (20,000 units at $67.59) as part of a pre-agreed trading plan (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- Director Schmertzler Michael sold $1,806,509 worth of shares (25,000 units at $72.26) as part of a pre-agreed trading plan (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- Director Schmertzler Michael sold $1,805,411 worth of shares (25,000 units at $72.22) as part of a pre-agreed trading plan (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- EXEC. VP AND CLO Boulding Mark Elliott exercised 2,813 shares at a strike of $25.69 and sold $204,127 worth of shares (2,813 units at $72.57) as part of a pre-agreed trading plan (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- CHIEF EXECUTIVE OFFICER Klein Matthew B. sold $705,722 worth of shares (10,292 units at $68.57), decreasing direct ownership by 3% to 383,868 units (SEC Form 4) to cover taxes4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- Director Sollie-Zetlmayer Hege Elisabeth was granted 6,000 shares, increasing direct ownership by 13% to 52,526 units (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- New insider Sollie-Zetlmayer Hege Elisabeth claimed ownership of 46,526 shares (SEC Form 3)3 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- CHIEF FINANCIAL OFFICER Gravier Pierre sold $280,743 worth of shares (3,494 units at $80.35), decreasing direct ownership by 4% to 83,986 units (SEC Form 4) to satisfy withholding obligation4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- CHIEF TECHNICAL OPS OFFICER Almstead Neil Gregory exercised 2,464 shares at a strike of $46.54 and sold $222,376 worth of shares (2,464 units at $90.25) as part of a pre-agreed trading plan (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- Director Smith Mary L. exercised 15,834 shares at a strike of $42.95 and sold $1,425,060 worth of shares (15,834 units at $90.00) as part of a pre-agreed trading plan (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- CHIEF TECHNICAL OPS OFFICER Almstead Neil Gregory exercised 46,774 shares at a strike of $38.86 and sold $4,093,482 worth of shares (46,774 units at $87.52) as part of a pre-agreed trading plan (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- EXEC. VP AND CLO Boulding Mark Elliott sold $432,118 worth of shares (5,079 units at $85.08) as part of a pre-agreed trading plan and exercised 5,079 shares at a strike of $43.36 (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- CHIEF TECHNICAL OPS OFFICER Almstead Neil Gregory exercised 8,130 shares at a strike of $38.10 and sold $693,151 worth of shares (8,130 units at $85.26) as part of a pre-agreed trading plan (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- CHIEF TECHNICAL OPS OFFICER Almstead Neil Gregory exercised 26,283 shares at a strike of $38.11 and sold $2,254,463 worth of shares (26,283 units at $85.78) as part of a pre-agreed trading plan (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- CHIEF TECHNICAL OPS OFFICER Almstead Neil Gregory exercised 23,749 shares at a strike of $25.69 and sold $1,921,378 worth of shares (23,749 units at $80.90) as part of a pre-agreed trading plan (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- EXEC. VP AND CLO Boulding Mark Elliott exercised 10,522 shares at a strike of $46.54 and sold $822,868 worth of shares (10,462 units at $78.65) as part of a pre-agreed trading plan, increasing direct ownership by 0.06% to 105,272 units (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- SVP, CHIEF ACCOUNTING OFFICER Utter Christine Marie exercised 19,686 shares at a strike of $25.69 and sold $1,487,474 worth of shares (19,686 units at $75.56) as part of a pre-agreed trading plan (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- CHIEF BUSINESS OFFICER Pauwels Eric sold $1,595,775 worth of shares (21,277 units at $75.00) as part of a pre-agreed trading plan and exercised 17,566 shares at a strike of $18.01, decreasing direct ownership by 5% to 73,411 units (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- EXEC. VP AND CLO Boulding Mark Elliott sold $202,958 worth of shares (2,812 units at $72.18) as part of a pre-agreed trading plan and exercised 2,812 shares at a strike of $25.69 (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- CHIEF EXECUTIVE OFFICER Klein Matthew B. sold $917,154 worth of shares (12,572 units at $72.95) and was granted 12,500 shares, decreasing direct ownership by 0.02% to 393,998 units (SEC Form 4) to satisfy tax liability4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- EXEC. VP AND CLO Boulding Mark Elliott exercised 3,540 shares at a strike of $46.54 and sold $279,570 worth of shares (3,540 units at $78.97) as part of a pre-agreed trading plan (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- CHIEF EXECUTIVE OFFICER Klein Matthew B. sold $202,094 worth of shares (2,850 units at $70.91), decreasing direct ownership by 0.72% to 394,070 units (SEC Form 4) to satisfy withholding tax4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- SEC Form 4 filed by Boulding Mark Elliott4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- SEC Form 4 filed by Golden Lee Scott4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- SEC Form 4 filed by Almstead Neil Gregory4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- SEC Form 4 filed by Chutter Jessica Caroline4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- SEC Form 3 filed by new insider Chutter Jessica Caroline3 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- CHIEF EXECUTIVE OFFICER Klein Matthew B. was granted 12,500 shares and sold $170,581 worth of shares (2,662 units at $64.08), increasing direct ownership by 3% to 396,920 units (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- Director Okey Stephanie exercised 15,167 shares at a strike of $33.63 and sold $1,061,690 worth of shares (15,167 units at $70.00) (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- CHIEF TECHNICAL OPS OFFICER Almstead Neil Gregory sold $252,823 worth of shares (3,989 units at $63.38) (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- EVP & CHIEF MEDICAL OFFICER Golden Lee Scott sold $633,800 worth of shares (10,000 units at $63.38), decreasing direct ownership by 11% to 79,944 units (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- Director Okey Stephanie sold $401,386 worth of shares (6,333 units at $63.38), decreasing direct ownership by 44% to 8,000 units (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- EXEC. VP AND CLO Boulding Mark Elliott sold $209,763 worth of shares (3,019 units at $69.48), decreasing direct ownership by 3% to 105,212 units (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- CHIEF BUSINESS OFFICER Pauwels Eric sold $209,398 worth of shares (3,019 units at $69.36), decreasing direct ownership by 4% to 77,122 units (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- CHIEF EXECUTIVE OFFICER Klein Matthew B. sold $511,253 worth of shares (7,371 units at $69.36), decreasing direct ownership by 2% to 387,082 units (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- SVP, CHIEF ACCOUNTING OFFICER Utter Christine Marie sold $172,984 worth of shares (2,494 units at $69.36), decreasing direct ownership by 3% to 70,199 units (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- CHIEF FINANCIAL OFFICER Gravier Pierre sold $207,525 worth of shares (2,992 units at $69.36), decreasing direct ownership by 3% to 87,318 units (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- EVP & CHIEF MEDICAL OFFICER Golden Lee Scott sold $172,290 worth of shares (2,484 units at $69.36), decreasing direct ownership by 3% to 89,944 units (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- CHIEF TECHNICAL OPS OFFICER Almstead Neil Gregory sold $216,473 worth of shares (3,121 units at $69.36), decreasing direct ownership by 3% to 112,140 units (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- EXEC. VP AND CLO Boulding Mark Elliott exercised 2,813 shares at a strike of $25.69 and sold $408,613 worth of shares (5,894 units at $69.33), decreasing direct ownership by 3% to 108,231 units (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- SVP, CHIEF ACCOUNTING OFFICER Utter Christine Marie sold $79,049 worth of shares (1,034 units at $76.45), decreasing direct ownership by 1% to 72,693 units (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- EXEC. VP AND CLO Boulding Mark Elliott sold $489,081 worth of shares (6,347 units at $77.06), decreasing direct ownership by 5% to 111,312 units (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- EVP & CHIEF MEDICAL OFFICER Golden Lee Scott sold $66,206 worth of shares (866 units at $76.45), decreasing direct ownership by 0.93% to 92,428 units (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- CHIEF EXECUTIVE OFFICER Klein Matthew B. sold $192,195 worth of shares (2,514 units at $76.45), decreasing direct ownership by 0.63% to 394,453 units (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- CHIEF BUSINESS OFFICER Pauwels Eric sold $565,946 worth of shares (7,348 units at $77.02), decreasing direct ownership by 8% to 80,141 units (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- CHIEF TECHNICAL OPS OFFICER Almstead Neil Gregory sold $71,863 worth of shares (940 units at $76.45), decreasing direct ownership by 0.76% to 115,196 units (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- SVP, CHIEF ACCOUNTING OFFICER Utter Christine Marie sold $201,919 worth of shares (2,616 units at $77.19), decreasing direct ownership by 3% to 73,727 units (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- CHIEF FINANCIAL OFFICER Gravier Pierre sold $164,596 worth of shares (2,139 units at $76.95), decreasing direct ownership by 2% to 90,310 units (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- CHIEF EXECUTIVE OFFICER Klein Matthew B. sold $629,895 worth of shares (8,165 units at $77.15), decreasing direct ownership by 2% to 396,967 units (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- CHIEF BUSINESS OFFICER Pauwels Eric sold $242,417 worth of shares (3,141 units at $77.18), decreasing direct ownership by 3% to 87,489 units (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- EVP & CHIEF MEDICAL OFFICER Golden Lee Scott sold $152,855 worth of shares (1,982 units at $77.12), decreasing direct ownership by 2% to 93,294 units (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- EXEC. VP AND CLO Boulding Mark Elliott sold $511,641 worth of shares (6,618 units at $77.31) and exercised 3,376 shares at a strike of $38.10, decreasing direct ownership by 3% to 117,659 units (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- CHIEF TECHNICAL OPS OFFICER Almstead Neil Gregory sold $186,098 worth of shares (2,411 units at $77.19), decreasing direct ownership by 2% to 116,077 units (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)
- Director Smith Mary L. was granted 4,000 shares, increasing direct ownership by 22% to 21,813 units (SEC Form 4)4 - PTC THERAPEUTICS, INC. (0001070081) (Issuer)